Overview

Targeting Inflammation in Acute Coronary Syndrome Using Colchicine

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of colchicine on high sensitivity C-reactive protein (hs-CRP), a blood marker to measure inflammation, in patients with acute coronary syndromes.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Treatments:
Colchicine